Phase I Dose-Escalation Study Of Azacitidine In Combination With Temozolomide
Columbia University
Columbia University
Ipsen
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
Mayo Clinic
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
INSYS Therapeutics Inc